Reuters Health News 要約
に引き続いて is a 要約 of 現在の health news 簡潔な／要約するs.
Trump 行政 指名するs new U.S. 麻薬 施行 長，指導者
The Trump 行政 on Monday 指名するd a 最高の，を越す White House lawyer as the new 長，率いる of the U.S. 麻薬 施行 行政 after the 機関's 事前の 事実上の／代理 行政官／管理者 発表するd his 退職 last month. Uttam Dhillon, who most recently served as 副 White House counsel, was 指名するd as the DEA's 事実上の／代理 行政官／管理者 at a time when the 機関 is 充てるing much of its attention to grappling with a 国家の opioid 疫病／流行性の.
Minor 一打／打撃 needs quick 医療の attention, too
Minor 一打／打撃s and "小型の-一打／打撃s," or transient ischemic attacks (TIAs), need 早期に 医療の attention, just like major 一打／打撃s, but a public education （選挙などの）運動をする in the UK had little success 納得させるing the public to 行為／法令／行動する 急速な／放蕩な after these events. "Although the （選挙などの）運動をする worked 井戸／弁護士席 for 行為 after more major 一打／打撃, 患者s were still slow to 行為／法令／行動する on, or ignored 完全に, the symptoms of minor events," said Dr. Peter M. Rothwell from John Radcliffe Hospital, University of Oxford.
Sanofi beefs up 糖尿病 pipeline to retrieve success
Sanofi sees a more diversified pipeline 運動ing a return to growth at its 糖尿病 部隊 in the coming years and will consider 取得／買収s and 共同s to help 上げる 業績／成果, a company (n)役員／(a)執行力のある said on Tuesday. The French drugmaker's 糖尿病 歳入s have fallen since 2015, 低迷ing some 11 パーセント last year alone, as its 特許-満了する／死ぬd Lantus insulin is 存在 squeezed by pricing 圧力 in the 部隊d 明言する／公表するs, the world's-largest health market.
Roche '高度に encouraged' by Tecentriq results in breast 癌
スイスの drugmaker Roche said on Monday that a 裁判，公判 showed its immunotherapy Tecentriq 加える the chemotherapy Abraxane 意味ありげに 減ずるd the 危険 of 病気 より悪くするing or death in people with metastatic ３倍になる 消極的な breast 癌. The company, 特記する／引用するing its IMpassion130 熟考する／考慮する, said it also 記録，記録的な／記録するd an encouraging 全体にわたる 生き残り 利益 for the PD-L1 肯定的な 全住民, whose tumors 表明する a protein that help them 避ける 免疫の system （犯罪，病気などの）発見, at 暫定的な 分析.
Britain moves closer to 合法化するing medicinal use of cannabis
Britain moved a step closer to 合法化するing the medicinal use of cannabis after a 報告（する）／憶測 結論するd there are 利益s for 患者s as the 政府 reviews the 支配するs to 許す 麻薬s derived from the banned 工場／植物. Professor Sally Davies, 長，指導者 医療の officer for England, said in the 報告（する）／憶測 there is conclusive 証拠 that cannabis can help people who を煩う chronic 苦痛, 多重の sclerosis and chemotherapy-induced nausea and vomiting.
Breast 癌 外科医s don't always order genetic 実験（する）ing for 患者s
(Reuters Health) - Many breast 癌 患者s may 行方不明になる out on genetic 実験（する）s that could help pinpoint the ideal 治療 regimen at least in part because their 外科医s are uncomfortable discussing the プロの／賛成のs and 反対／詐欺s of these 実験（する）s, a U.S. 熟考する／考慮する 示唆するs. だいたい one-third of 患者s receive genetic 実験（する）ing after a diagnosis of breast 癌, and 実験（する）ing with a multigene パネル盤 is 速く 取って代わるing 実験（する）s based on just two - BRCA1 and BRCA2 - that have long been linked to 積極的な tumors, 研究員s 公式文書，認める in JAMA 外科. 現在の practice 指導基準s recommend genetic 実験（する）ing for breast 癌 患者s who have an elevated 危険 of genetic 突然変異s based on age, family history, and tumor 特徴.
U.S. defibrillator 調査（する） 減ずるd 疑わしい implantation 率
A U.S. 政府 調査 of 主張s that doctors were implanting heart-shocking defibrillators into 患者s who didn't 会合，会う 連邦の 指導基準s led to a 劇の 削減 in the number of implants and may have saved many 患者s from unnecessary 外科, 研究員s 報告（する）／憶測 in the 定期刊行物 of the American 医療の 協会.The 2010 司法省 調査（する） 伴う／関わるd Medicare 受取人s, but the new 研究 also 文書s a 類似の 減少（する） in defibrillator usage の中で 非，不，無-Medicare 受取人s.The number of unnecessary implantations 妨げるd by the 調査 is not known because "there are too many factors," 上級の author Dr. Jeptha Curtis of the Yale School of 薬／医学 in New 港／避難所, Connecticut told Reuters Health in a telephone interview.There may have been instances where 患者s didn't really need the implantable cardioverter-defibrillator they received, he said, "(but) I think that is probably the 少数，小数派 of 事例／患者s here."In other instances, doctors and hospitals might have inadequately 文書d the 推論する／理由s for the implantation or failed to 正確に follow the 指導基準s - for example, by implanting a defibrillator 39 days after a heart attack when the 指導基準s call for waiting at least 40 days, he said.Nonetheless, more than 500 hospitals 最終的に paid the 政府 over $270 million in 刑罰，罰則s for implantations that failed to 適合する to the 指導基準s.The 熟考する／考慮する team 設立する that after the 連邦の 調査 was 発表するd, the 拒絶する／低下する in implantations was 劇の.In 2007, の中で hospitals that were 運命にあるd to reach a 解決／入植地 with the 政府, 25.8 パーセント of the implanted defibrillators did not 会合，会う 連邦の 指導基準s. By 2012, that 率 had dropped a whopping 16.1 百分率 points.For hospitals not 許可／制裁d in the 調査, the starting 率 of implantation outside the 指導基準s was 22.8 パーセント; that 率 subsequently 拒絶する／低下するd by 12.1 百分率 points.類似の 拒絶する／低下するs were seen in 患者s not covered by Medicare, Curtis said. "It seems like the 影響 of the 調査 延長するd to all 候補者s for defibrillators."The 拒絶する／低下する was not seen の中で 患者s whose hearts had already stopped once and who 明確に needed an ICD as soon as possible."Many 不適切な 手続きs were likely 避けるd," 令状s Dr. Paul Heidenreich, of the Stanford University School of 薬／医学 in California, in an …を伴ってing 編集（者）の.The new 研究 looked at data from 1,809 hospitals, 452 of which reached 解決／入植地s with the 政府.Curtis said the results show that 患者s should be asking their doctor hard questions. "If someone 申し込む／申し出s you an invasive 手続き like a defibrillator that carries with it a long 称する，呼ぶ／期間／用語 かかわり合い, it's important to have a very 詳細（に述べる）d discussion on the 証拠 of the 利益 and the 危険 of the 手続き."He said 患者s can go to the website patientdecisionaid.org to see the types of questions they should be asking their doctor.The U.S. Department of Health and Human Services 回復するd $2.6 billion in all types of fraudulent （人命などを）奪う，主張するs and expenses in 会計年度 2017, 代表するing about $4 for every dollar spent 調査／捜査するing 主張s, Heidenreich 公式文書，認めるs. "Given this 抱擁する 投資 (and return) it seems reasonable to 投資する more in 組織／基盤／下部構造 to 正確に 手段 and 跡をつける care," he 令状s.SOURCE: http://bit.ly/2KoetVH JAMA, online July 3, 2018.
AstraZeneca 勝利，勝つs 迅速な 是認s for 癌 麻薬s in Japan
AstraZeneca has won 早い regulatory 是認 for new uses of two of its important 癌 麻薬s in Japan, いっそう少なく than six months after the first 全世界の 是認s in Western markets. The 決定／判定勝ち（する）s by the Japanese 省 of Health, 労働 and 福利事業 反映する an 増加するd 緊急 by 公式の／役人s in the country to 接近 modern 薬／医学s, after many years of slow 採択.
Fertility problems, reproductive 科学（工学）技術 tied to わずかに more birth defects
(Reuters Health) - Women who struggle to get 妊娠している or use reproductive 科学（工学）技術s like in vitro fertilization (IVF) may be more likely to have preemies and kids with birth defects than their peers who conceive without difficulty, a U.S. 熟考する／考慮する 示唆するs. Infertility has long been linked to an 増加するd 危険 of premature 配達／演説／出産s, and the 現在の 熟考する／考慮する 申し込む／申し出d fresh 証拠 of this. Compared to women without any fertility 問題／発行するs, women who struggled to conceive were 39 パーセント more likely to have premature babies, while the 増加するd 危険 associated with using reproductive 科学（工学）技術s was 79 パーセント.
麻薬 use in Kenya's coast communities up as West-bound ヘロイン flows through
ヘロイン use is 増加するing in Kenya's 沿岸の communities as international traffickers use them as a 輸送 point for 麻薬s bound from Afghanistan to the West, creating health and social problems, a European Union-基金d 報告（する）／憶測 said on Tuesday. The port cities of Mombasa, Malindi and Lamu have been 特に hard 攻撃する，衝突する in 最近の years, it said.
